CRISPR-Cas9 for in vivo Gene Therapy: Promise and Hurdles
Wei-Jing Dai, Liyao Zhu, Zhongyi Yan, Yong Xu, Qilong Wang, Xiaojie Lu
- ISSN / E-ISSN
- — / —
- DOI
- 10.1038/mtna.2016.58 ↗
- Volume · Issue · Pages
- 5 · — · e349-e349
- Publisher
- Cell Press
- Article URL
- https://doi.org/10.1038/mtna.2016.58 ↗
- Article details
- Unverified
Publication date (each date has its type and source)
01 Jan 2016
OpenAlex publication date · source: OpenAlex
| Type | Date | Source |
|---|---|---|
| OpenAlex publication date | 01 Jan 2016 | OpenAlex |
Keywords (as given): CRISPR/Cas9; in vivo gene therapy; genome editing; off-target effects; homology-directed repair; immunogenicity; in vivo delivery; translational barriers
HEC Status at Publication Not the journal's current status
HEC Status at PublicationNot conclusive
Historical status could not be conclusively determined.
- HEC status cannot be determined for this date: no HEC list is recorded as in effect on it.
Best available information, not a definitive status: HEC status cannot be determined for this date: no HEC list is recorded as in effect on it.
- Journal
- Molecular Therapy - Nucleic Acids
- Publication date used
- 01 Jan 2016 (OpenAlex publication date)
- Applicable HEC period
- None recorded for this date
- Category
- —
- Recognition status
- Unknown (NO_PERIOD_FOR_DATE)
- Source
- —
- Verification status
- Not available
This is an automatically generated summary based on the information available on the publication date. Terms & conditions apply.